Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions

Breast Cancer

Volumn 16, Issue 3, 2009, Pages 173-178

  Moriya, Takuya ^a   Kanomata, Naoki ^a   Kozuka, Yuji ^a   Fukumoto, Motoi ^a   Iwachido, Nobuhisa ^a   Hata, Sakae ^a   Takahashi, Yayoi ^b   Miura, Hiroshu ^b   Ishida, Kazuyuki ^b   Watanabe, Mika ^b  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Breast; Cytokeratin; Immunohistochemistry; Myoepithelial cells; Pathology

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN; HIGH MOLECULAR WEIGHT CYTOKERATIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ASPIRATION BIOPSY; BREAST FIBROMA; BREAST LESION; BREAST PAPILLOMA; BREAST TUMOR; CANCER SCREENING; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL EVALUATION; CLINICAL FEATURE; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; EPITHELIUM; EXCISION; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; INVASIVE DUCTAL CARCINOMA; MAMMOGRAPHY; MYOEPITHELIUM CELL; NONINVASIVE DUCTAL CARCINOMA; PAPILLOMA; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SOLID TUMOR; STAINING; STROMA; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, DUCTAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LABORATORY TECHNIQUES AND PROCEDURES; MIDDLE AGED; MYOEPITHELIOMA; PAPILLOMA, INTRADUCTAL; TUMOR MARKERS, BIOLOGICAL;

EID: 68349114999     PISSN: 13406868     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12282-009-0127-7     Document Type: Review

References (21)

1. T Moriya Y Kozuka N Kanomata GM Tse PH Tan 2009 The role of immunohistochemistry in the differential diagnosis of breast lesions Pathology 41 68 76
2. T Moriya A Kasajima K Ishida Y Kariya J Akahira M Endoh 2006 New trends of immunohistochemistry for making differential diagnosis of breast lesions Med Mol Morphol 39 8 13
3. The Japanese Breast Cancer Society 2005 Histological classification Breast Cancer 12 S12 S14
4. T Oyama FC Koener 2004 Noninvasive papillary proliferations Sem Diagn Pathol 21 32 41
5. A Mulligan FP O'Malley 2007 Papillary lesions of the breast. A review Adv Anat Pathol 14 108 119
6. LC Collins SJ Schnitt 2008 Papillary lesions of the breast. Selected diagnostic and management issues Histopathology 52 20 29
7. R Bhargava DJ Dabbs 2007 Use of immunohistochemistry in diagnosis of breast epithelial lesions Adv Anat Pathol 14 93 107
8. X Wang I Mori W Tang M Nakamura Y Nakamura M Sato 2002 P63 expression in normal, hyperplastic and malignant breast tissues Breast Cancer 9 216 219
9. GM Tse PH Tan PC Lui CB Gilks CS Poon TK Ma 2007 The role of immunohistochemistry for smooth muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of the breast J Clin Pathol 60 315 320
10. S Ichihara T Fijimoto K Hashimoto S Moritani M Hasegawa T Yokoi 2007 Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesion of the breast Pathol Int 57 126 132
11. W Bocker H Burger IB Buchwalow T Decker 2005 CK5-positive cells are precursor cells of glandular and myoepithelial cell lineages in the human breast epithelium. A new cell concept as a basis for a better understanding of proliferative breast disease? Verh Dtsch Ges Pathol 89 45 47
12. PH Tan MY Aw G Yip BH Bay LH Sil S Murugaya 2005 Cytokeratins in papillary lesions of the breast. Is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol 29 625 632
13. MF Lerwill 2004 Current practical applications of diagnostic immunohistochemistry in breast pathology Am J Surg Pathol 28 1076 1091
14. H Nassar H Qureshi N Volkanadsay D Visscher 2006 Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas Am J Surg Pathol 30 501 507
15. T Kawasaki S Nakamura G Sakamoto S Murata H Tsunoda-Shimizu K Suzuki 2008 Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast. Comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases Histopathology 41 288 298
16. S Moritani S Ichihara R Kushima H Okabe M Bamba TK Kobayashi 2007 Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast. A potential diagnostic pitfall and a proposal of an immunohistochemical panel in the diagnosis with intraductal papilloma with usual ductal hyperplasia Virchows Arch 450 539 547
17. J Rabban FC Koerner MF Lerwill 2006 Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6 Hum Pathol 37 787 793
18. Y Otsuki M Yamada S Shimizu K Suwa M Yoshida F Tanioka 2007 Solid-papillary carcinoma of the breast. Clinicopathological study of 20 cases Pathol Int 57 421 429 (Pubitemid 46976409)
19. GM Tse PH Tan B Chaiwun TC Putti PC Lui AK Tsang 2006 P63 is useful in the diagnosis of mammary metaplastic carcinomas Pathology 38 16 20
20. CB Hill IT Yeh 2005 Myoepithelial cell staining patterns of papillary breast lesions. From intraductal papillomas to invasive papillary carcinomas Am J Clin Pathol 123 36 44
21. MM Nicolas Y Wu LP Middleton MZ Gilcrease 2007 Loss of myoepithelium is variable in solid papillary carcinoma of the breast Histopathology 51 657 665